MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- B7738 SR 35761 CitationTarget: JNKSummary: JNK3 inhibitor, potent and selective
- B7748 DBM 1285 dihydrochlorideSummary: p38 MAPK inhibitor
- B5727 PD 334581Summary: MEK1 inhibitor
- A3004 Vemurafenib (PLX4032, RG7204)9 CitationTarget: RafSummary: BRAF kinase inhibitor
- A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
- A3013 PD03259015 CitationSummary: MEK inhibitor
- A3016 PLX-47201 CitationTarget: RafSummary: BRAF kinase inhibitor
- A3018 Trametinib (GSK1120212)7 CitationTarget: MEKSummary: MEK1 and MEK2 inhibitor
- A3189 AS 602801Summary: Jun Kinase Inhibitor
- A3263 BRAF inhibitorSummary: Potent B-raf inhibitor